Validity of the INR System for Patients with Liver Impairment

Please copy the URL and add it into your RSS Feed Reader.

Facebook Linkedin Weibo

Thromb Haemost 1995; 73(01): 162
DOI: 10.1055/s-0038-1653742

Letter to the Editor

Schattauer GmbH Stuttgart

K W E Denson

Thame Thrombosis and Haemostasis Research Foundation, Thame, Oxon, UK

,

S V Reed

Thame Thrombosis and Haemostasis Research Foundation, Thame, Oxon, UK

,

M E Haddon

Thame Thrombosis and Haemostasis Research Foundation, Thame, Oxon, UK

Further Information

Publication History

Publication Date:
09 July 2018 (online)

References
1 Kovacs MJ, Wong A, MacKinnon K, Weir K, Keeney M, Boyle E, Cruickshank M. Assessment of the validity of the INR system for patients with liver impairment. Thromb Haemost 1994; 71: 727-730

MissingFormLabel
Thieme Connect PubMed Search in Google Scholar
2 Hemker HC, Hemker PW. Kinetic aspects of the interaction of blood clotting enzymes. IV. Kinetics of competitive inhibitor of clotting tests Throm Diath Haemorr 1968; 19: 364-378

MissingFormLabel
PubMed Search in Google Scholar
3 Denson KW E. Thromboplastin-sensitivity, precision and other characteristics. Clin lab Haemat 1988; 18: 315-328

MissingFormLabel
PubMed Search in Google Scholar